close
Investment
4 mins to read

Unusual times ‘still ankle tapping us’: FPH boss

Medical device manufacturer’s share price jumps nearly 7% after beating interim guidance.

Fisher Paykel managing director and chief executive Lewis Gradon.

Key points
  • Revenue: Up 16% to $803.7 million, and above guidance of about $790m.
  • Profit: Up 12% to $107.3m, and above guidance of between $95m and $105m.
  • Main takeaway: Questions have been raised about long-term growth expectations in a post-Covid world.

Analysts have probed the boss of Fisher & Paykel Healthcare about the longer-term growth expectations of hospital consumable sales after the listed device manufacturer reported interim results ahead of guidance.

The company today said its net profit after tax for the six months ended September 30

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Contact the Writer: Hmcnicol@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Key points
  • Revenue: Up 16% to $803.7 million, and above guidance of about $790m.
  • Profit: Up 12% to $107.3m, and above guidance of between $95m and $105m.
  • Main takeaway: Questions have been raised about long-term growth expectations in a post-Covid world.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Unusual times ‘still ankle tapping us’: FPH boss
Investment,
101914